News
RZL-012 is an injectable treatment for focal fat reduction that is currently progressing toward Phase 3 trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback